Pages that link to "Q35225468"
Jump to navigation
Jump to search
The following pages link to Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study (Q35225468):
Displaying 50 items.
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary (Q22241786) (← links)
- Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes (Q26749281) (← links)
- Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making (Q26992979) (← links)
- Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists (Q28077026) (← links)
- Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes. (Q30253045) (← links)
- Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes (Q30666747) (← links)
- Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study (Q33629805) (← links)
- Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters (Q33727475) (← links)
- Effects of Exercise in the Fasted and Postprandial State on Interstitial Glucose in Hyperglycemic Individuals (Q33782775) (← links)
- Impact of postprandial hyperglycemia at clinic visits on the incidence of cardiovascular events and all-cause mortality in patients with type 2 diabetes (Q33871377) (← links)
- BRIGHT Guidelines on Self-Monitoring of Blood Glucose (Q34176357) (← links)
- A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study (Q34329486) (← links)
- Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? (Q34486820) (← links)
- The immediate effects of a single bout of aerobic exercise on oral glucose tolerance across the glucose tolerance continuum (Q34582349) (← links)
- A review of cardiovascular outcomes in the treatment of people with type 2 diabetes (Q34726469) (← links)
- HbA1C variability and the risk of renal status progression in Diabetes Mellitus: a meta-analysis (Q34734227) (← links)
- Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome (Q34999016) (← links)
- Utility of different glycemic control metrics for optimizing management of diabetes (Q35049855) (← links)
- Glucose and triglyceride excursions following a standardized meal in individuals with diabetes: ELSA-Brasil study. (Q35085599) (← links)
- Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study (Q35117192) (← links)
- Importance of Beta Cell Function for the Treatment of Type 2 Diabetes (Q35667116) (← links)
- Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes (Q35845203) (← links)
- One bout of exercise alters free-living postprandial glycemia in type 2 diabetes (Q35907035) (← links)
- Fast food increases postprandial cardiac workload in type 2 diabetes independent of pre-exercise: A pilot study (Q35949618) (← links)
- High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets (Q36339645) (← links)
- Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality (Q36392849) (← links)
- Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial (Q36633079) (← links)
- Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study (Q36682246) (← links)
- The Economic Burden of Post-prandial Hyperglycemia (PPH) Among People with Type 1 and Type 2 Diabetes in Three Countries (Q36712197) (← links)
- Understanding Post-Prandial Hyperglycemia in Patients with Type 1 and Type 2 Diabetes: A Web-based Survey in Germany, the UK, and USA. (Q36989716) (← links)
- Effects of different proportion of carbohydrate in breakfast on postprandial glucose excursion in normal glucose tolerance and impaired glucose regulation subjects (Q37006655) (← links)
- Sitagliptin reduces hyperglycemia and increases satiety hormone secretion more effectively when used with a novel polysaccharide in obese Zucker rats (Q37033531) (← links)
- Frequent interruptions of sedentary time modulates contraction- and insulin-stimulated glucose uptake pathways in muscle: Ancillary analysis from randomized clinical trials. (Q37198711) (← links)
- Ideal glycated hemoglobin cut-off points for screening diabetes and prediabetes in a Chinese population (Q37227381) (← links)
- Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials (Q37568863) (← links)
- Orange Pomace Improves Postprandial Glycemic Responses: An Acute, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial in Overweight Men. (Q37673197) (← links)
- Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus (Q37692779) (← links)
- A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress (Q37694033) (← links)
- Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. (Q38016729) (← links)
- The role of self-monitoring of blood glucose in glucagon-like peptide-1-based treatment approaches: a European expert recommendation (Q38024383) (← links)
- The role of oxidative stress in postprandial endothelial dysfunction (Q38061799) (← links)
- Taking small steps towards targets - perspectives for clinical practice in diabetes, cardiometabolic disorders and beyond. (Q38092138) (← links)
- Self-monitoring of blood glucose in type 2 diabetes: recent studies (Q38097223) (← links)
- Exercise lowers postprandial glucose but not fasting glucose in type 2 diabetes: a meta-analysis of studies using continuous glucose monitoring. (Q38137973) (← links)
- Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. (Q38158229) (← links)
- The role of self-monitoring of blood glucose in patients treated with SGLT-2 inhibitors: a European expert recommendation (Q38215995) (← links)
- Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus (Q38219481) (← links)
- The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus. (Q38239573) (← links)
- High-intensity interval training for improving postprandial hyperglycemia. (Q38269921) (← links)
- Pharmacogenomics of glinides. (Q38307994) (← links)